Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 6/20 | 0.68 |
| ▸ | PIK3CA | P42336 | 4/20 | 0.62 |
| ▸ | AURKA | O14965 | 1/20 | 0.62 |
| ▸ | CDK1 | P06493 | 1/20 | 0.62 |
| ▸ | NEK2 | P51955 | 1/20 | 0.62 |
| ▸ | PLK1 | P53350 | 1/20 | 0.62 |
| ▸ | PIK3R1 | P27986 | 2/20 | 0.42 |
| ▸ | EED | O75530 | 3/20 | 0.38 |
| ▸ | SUZ12 | Q15022 | 3/20 | 0.38 |
| ▸ | EZH2 | Q15910 | 3/20 | 0.38 |
| ▸ | RBBP4 | Q09028 | 1/20 | 0.38 |
| ▸ | RBBP7 | Q16576 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 8/20 | 0.36 |
| ▸ | TDO2 | P48775 | 8/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2258148 | 1.00 | APP (0.68) | APPPIK3CAAURKACDK1NEK2 | |
| SCHEMBL8226303 | 1.00 | APP (0.68) | APPPIK3CAAURKACDK1NEK2 | |
| SCHEMBL20203938 | 0.87 | APP (0.51) | APPPIK3CAAURKACDK1NEK2 | |
| SCHEMBL19194047 | 0.87 | APP (0.71) | APPPIK3CAAURKACDK1NEK2 | |
| SCHEMBL20199947 | 0.84 | APP (0.68) | APPPIK3CAAURKACDK1NEK2 | |
| Viridin SCHEMBL150042 | 0.81 | APP (0.68) | APPPIK3CAAURKACDK1NEK2 | |
| Viridin SCHEMBL12162187 | 0.81 | APP (0.68) | APPPIK3CAAURKACDK1NEK2 | |
| Viridin SCHEMBL150041 | 0.81 | APP (0.68) | APPPIK3CAAURKACDK1NEK2 | |
| SCHEMBL19198458 | 0.81 | APP (1.00) | APPPIK3CAAURKACDK1NEK2 | |
| SCHEMBL12464245 | 0.81 | APP (1.00) | APPPIK3CAAURKACDK1NEK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11019825-B2 | Product | ALPHA BIOPESTICIDES LIMITED (GB) | 2021-06-01 | — | — | US | disclosed |
| US-20180146683-A1 | NEW PRODUCT | ALPHA BIOPESTICIDES LIMITED (GB) | 2018-05-31 | — | — | US | disclosed |
| WO-2016189329-A1 | NEW PRODUCT | ALPHA BIOPESTICIDES LIMITED (GB) | 2016-12-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180146683-A1 | NEW PRODUCT | CYP51A1, ERG28, FASN | APP 2710/4885PIK3CA 2188/4885AURKA 1490/4885 |
| US-11019825-B2 | Product | ERG28, FASN, CYP51A1 | APP 1726/4885PIK3CA 2060/4885AURKA 1228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.